Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04002336 · ClinicalTrials.gov registry record · NA
Testing a Smart Phone App to Enhance Voice Therapy Adherence
A NA study of Voice Disorders, sponsored by Vrushali Angadi.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
- 1
- Study location
NCT04002336: Completed NA study of Voice Disorders, sponsored by Vrushali Angadi.
NCT04002336 is a NA study of Voice Disorders that has completed, run by Vrushali Angadi. The registered enrollment target is 33 participants, below the 92-participant average among 7 other Voice Disorders trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04002336, a NA study of Voice Disorders, has completed, sponsored by Vrushali Angadi.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
The current project is designed as phase 1 study conducted to improve/enhance normal voice. Fifteen Thirty non-treatment seeking individuals, with no identifiable vocal pathology on laryngeal examination, will be randomized to one of two groups; 1) Voice therapy delivery without App (control/standard of care), 2) Voice therapy delivery with app (experimental). Participants in both groups will attend weekly voice therapy sessions (for 6 weeks) with the PI and Co- I (Joseph Stemple). Control group participants will be provided with an audio file of the exercises, and an exercise log sheet to track progress. Experimental group participants will use the smartphone app, which allows participants to record home practice sessions in real time and upload sessions to the app server for the clinician to access and track. Three-wave surveys will be conducted at the baseline, four weeks and 6 weeks after the intervention. Other data sources include study administration, exercise logs, app data, and clinical assessment.
Primary Outcome
Number of completed home practice sessions
Conditions Studied
Interventions
- BEHAVIORAL Traditional Voice therapy
- BEHAVIORAL Voice Therapy App
Study Locations (1)
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2018-11-30 |
| Phase | NA |
What the finished NCT04002336 record still lists
NCT04002336 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 92-participant average among 7 other Voice Disorders trials with a reported enrollment target (64% lower).
The record links to 1 condition, with Voice Disorders appearing as the primary indexed condition, and to 2 interventions - of which Traditional Voice therapy is the first listed.
NCT04002336 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT04002336 about?
NCT04002336 is a clinical study titled "Testing a Smart Phone App to Enhance Voice Therapy Adherence". The current project is designed as phase 1 study conducted to improve/enhance normal voice. Fifteen Thirty non-treatment seeking individuals, with no identifiable vocal pathology on laryngeal examination, will be randomized to one of two groups; 1) Voice therapy delivery without App (control/standar...
What is the current status of trial NCT04002336?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2018-10-01. Estimated completion is 2018-11-30.
What conditions does trial NCT04002336 study?
This clinical trial studies the following conditions: Voice Disorders.
What interventions are being tested in trial NCT04002336?
The interventions under investigation include: Traditional Voice therapy (BEHAVIORAL), Voice Therapy App (BEHAVIORAL).
Who is sponsoring clinical trial NCT04002336?
This trial is sponsored by Vrushali Angadi, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04002336 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Voice Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Efficacy of Voice Therapy Concepts Via Telepractice and Mobile App Technology
RECRUITING · NA
-
Straw Phonation Exercise Program for Pitch Extension
ACTIVE NOT RECRUITING · NA
-
Dysphonia, Distress, and Perceived Control: Technology Based Assessment and Intervention
COMPLETED · NA
-
Project 4: Ambulatory Biofeedback and Voice Therapy for Patients With Vocal Hyperfunction
RECRUITING · Early Phase 1
-
Interaction of Caffeine and Hydration on Voice
COMPLETED · Early Phase 1
-
Brain Mapping of Voice Control
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI